Related Experiment Video
Updated: Jun 4, 2026

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
[Nicotine in infancy--QUIT for kids].
Jan Mazela1, T Ailen Merritt, Ewa Florek
1Ginekologiczno-Połozniczy Szpital Kliniczny, Katedra i Klinika Neonatologii, Uniwersytet Medyczny im. Karola Marcinkowskiego, Poznań. janco@pol-med.com.pl
Environmental tobacco smoke (ETS) exposure harms children, causing illnesses and behavioral issues. "The QUIT for kids" program aims to prevent infant exposure through education.
Area of Science:
- Pediatrics
- Environmental Health
- Public Health
Background:
- Environmental tobacco smoke (ETS) exposure during pregnancy and postnatally is linked to numerous infant health problems, including respiratory illnesses, asthma, and behavioral disturbances.
- A significant percentage of children (70-80%) are exposed to ETS in various environments, including public spaces and transportation.
- Maternal smoking and exposure to ETS can lead to toxicant transfer through breast milk, further endangering infants.
Purpose of the Study:
- To address the lack of individualized educational approaches for preventing infant exposure to environmental tobacco smoke.
- To establish an academic collaboration and develop the "The QUIT for kids" program.
Main Methods:
- The study highlights the need for targeted educational interventions.
- The establishment of "The QUIT for kids" program is presented as a solution.
Main Results:
- Infant exposure to environmental tobacco smoke is a significant public health concern.
- Existing educational approaches are insufficient to prevent widespread ETS exposure in children.
Conclusions:
- There is a critical need for focused, individualized educational strategies to protect infants from environmental tobacco smoke.
- "The QUIT for kids" program is proposed as an initiative to mitigate the adverse health effects of ETS on children.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
CNS Depressants: Alcohol and Nicotine
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Psychosexual Stages of Personality: Oral
Weaning, typically occurring around the age...
Drug Dependence
Drug Dosing: Infants and Children
